These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2668713)

  • 41. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome.
    Palomba S; Falbo A; Russo T; Manguso F; Tolino A; Zullo F; De Feo P; Orio F
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3128-35. PubMed ID: 17519312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome.
    Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S233-7. PubMed ID: 17606307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reactive hypoglycemia in lean young women with PCOS and correlations with insulin sensitivity and with beta cell function.
    Altuntas Y; Bilir M; Ucak S; Gundogdu S
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):198-205. PubMed ID: 15808380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
    Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
    J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
    Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
    Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.
    Ciampelli M; Leoni F; Cucinelli F; Mancuso S; Panunzi S; De Gaetano A; Lanzone A
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1398-406. PubMed ID: 15598698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
    Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
    J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Intravenous glucose tolerance test in the polycystic ovary syndrome].
    Relli P; Cotrozzi G; Matteini M; Lazzari T; Bufalini GN
    Boll Soc Ital Biol Sper; 1982 Nov; 58(22):1451-4. PubMed ID: 6762217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome.
    Sam S; Vellanki P; Yalamanchi SK; Bergman RN; Dunaif A
    Metabolism; 2017 Jun; 71():125-131. PubMed ID: 28521865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucose intolerance in the polycystic ovary syndrome: role of the pancreatic beta-cell.
    Ehrmann DA
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1299-301. PubMed ID: 11117674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin and insulin-like growth factor-I responsiveness in polycystic ovarian syndrome.
    Buyalos RP; Geffner ME; Bersch N; Judd HL; Watanabe RM; Bergman RN; Golde DW
    Fertil Steril; 1992 Apr; 57(4):796-803. PubMed ID: 1555690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome.
    Ding L; Gao F; Zhang M; Yan W; Tang R; Zhang C; Chen ZJ
    Fertil Steril; 2016 May; 105(5):1330-1337.e3. PubMed ID: 26868993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
    Takeuchi T; Tsutsumi O; Taketani Y
    Gynecol Endocrinol; 2008 Jul; 24(7):385-91. PubMed ID: 18645711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Inhibition of pancreatic beta-cell secretion during "glucose clamp" in patients with polycystic ovary syndrome].
    Randazzo C; Mistretta A; Pugliese A; Sinagra D
    Minerva Endocrinol; 1989; 14(2):109-13. PubMed ID: 2668713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.